期刊文献+

VGLL4在结肠癌组织内的表达及意义 被引量:2

Expression of VGLL4 in colon cancer and its significance
下载PDF
导出
摘要 目的分析VGLL4在结肠癌组织内的表达情况,探讨VGLL4在不同临床病理组织学结肠癌患者中的表达差异及其与预后的关系,以期为结肠癌的临床诊疗提供参考依据。方法收集120例结肠癌根治术患者标本,采用免疫组化法比较癌组织及癌旁组织的VGLL4表达情况,计算VGLL4的光密度值(IOD)值中位数,并依据其将患者分为VGLL4高表达组及低表达组。分析VGLL4的表达水平并探讨其与结肠癌患者临床、病理组织学及预后的关系。结果采用免疫组化法显示VGLL4在癌组织中的表达水平显著低于癌旁组织,差异有统计学意义(P<0.05)。对VGLL4在不同病理组织学结肠癌患者中的表达差异分析显示,VGLL4高表达与低表达组患者在性别、年龄、BMI、M分期上比较无统计学差异(P>0.05);而在肿瘤直径、T分期及N分期上比较差异有统计学意义(P<0.05)。采用Logistic回归模型对VGLL4表达的独立影响因素进行分析得出,T分期、肿瘤直径及TNM分期是VGLL4高表达的独立影响因素。VGLL4高表达组患者血清CEA水平显著低于低表达组,差异有统计学意义(P<0.05)。VGLL4高表达组患者血清中CA199水平与低表达组比较,差异无统计学意义(P>0.05)。Spearman相关性分析显示,结肠癌患者VGLL4表达水平与血清CEA水平呈显著负相关(r=-0.607,P<0.01)。VGLL4低表达组5年累积复发率高于高表达组,而5年累积死亡率低于高表达组(P<0.05);结论VGLL4在结肠癌组织表达水平显著低于癌旁组织,与肿瘤进展程度相关,且其水平降低提示预后不良。 Objective To analyze the expression of VGLL4 in colon cancer tissues,and to investigate the differential expression of VGLL4 in different clinicopathological histological cancer patients and its relationship with prognosis in order to provide reference for clinical diagnosis and treatment of rectal cancer.Methods The clinical data of 120 patients who underwent radical resection of rectal cancer in our hospital from January 2010 to January 2013 were included.Immunohistochemistry was used to compare the expression of VGLL4 in cancer tissues and adjacent tissues, and calculate the expression of VGLL4.The median value of optical density ( IOD) was divided into VGLL4 high expression group and low expression group.The expression level of VGLL4 was analyzed and its relationship with clinical,histopathology and prognosis of rectal cancer patients was discussed.Results Immunohistochemistry showed that the expression level of VGLL4 in cancer tissues was significantly lower than that in adjacent tissues ( P< 0.05).The difference of expression of VGLL4 was observed in different histopathological rectal cancer patients.The analysis showed that there was no significant difference in gender,age,BMI and M staging between the high-and lowexpression groups of VGLL4 ( P>0.05),but the difference in tumor diameter,T stage and N stage was statistically significant ( P<0.05);Logistic regression model was used to analyze the independent influencing factors of VGLL4 expression.T stage,tumor diameter and TNM stage were independent factors affecting the high expression of VGLL4. Serum CEA levels were significantly lower in patients with high expression of VGLL4.than that of the lower expression group ( P< 0.05 ).There was no significant difference in serum CA199 level between the VGLL4 high expression group and the low expression group ( P> 0.05).Spearman correlation analysis showed that in rectal cancer patients there was a significant negative correlation between VGLL4 expression level and serum CEA level ( r =- 0.607,P< 0.01).The 5-year cumulative recurrence rate of VGLL4 low expression group was higher than that of high expression group,and the 5-year cumulative survival rate was lower than that of high expression group ( P < 0.05 ). Conclusions VGLL4 expression level in rectal cancer tissues is significantly lower than that of adjacent tissues,and related to tumor progression.The decrease in its level suggests a poor prognosis.
作者 夏良兵 范振龙 胡思俊 肖卫 胡文辉 XIA Liang-bing;FAN Zhen-long;HU Si-jun;XIAO Wei;HU Wen-hui(Department of Pathology,Jianli People's Hospital,Jingzhou 433300,China)
出处 《诊断病理学杂志》 2019年第8期481-485,共5页 Chinese Journal of Diagnostic Pathology
关键词 VGLL4 结肠癌 免疫组化 病理组织学 预后 VGLL4 colon cancer immunohistochemistry histopathology prognosis
  • 相关文献

参考文献6

二级参考文献72

  • 1Wang W,Li Y,Zhang X.结直肠癌患者联合血浆CEA及其相关蛋白水平检测较单独检测血浆CEA具有更高敏感性[J].中华结直肠疾病电子杂志,2014,3(2):32-32. 被引量:11
  • 2余捷凯,杨美琴,姜铁军,郑树.血清肿瘤标志物优化组合人工神经网络模型在大肠癌诊断中的应用[J].浙江大学学报(医学版),2004,33(5):407-410. 被引量:22
  • 3李振良,李肖峰,徐康平.患者亲属——医疗决策的重要主体[J].医学与哲学(B),2007,28(2):4-7. 被引量:27
  • 4Murray E, Charles C, Gafni A, Shared decision-making in pri-mary care:tailoring the Charles et al. model to fit the contextof general practice [J]. Patient Educ Couns,2006,62 (2) :205-211.
  • 5Charles C,Gafni A,Whelan T. Shared decision-making in themedical encounter : what does it mean. (or it takes at least twoto tango)[J]. Soc Sci Med, 1997,44(5):681-692.
  • 6Butow P,Harrison JD,Choy ET,et al. Health professional andconsumer views on involving breast cancer patients in themultidisciplinary discussion of their disease and treatmentplan[J]. Cancer,2007,110(9) : 1937-1944.
  • 7Stacey D,Samant R,Bennett C. Decision making in oncology:areview of patient decision aids to support patient participation[J]. CA:a cancer journal for clinicians,2008,58(5):293-304.
  • 8Beaver K,Bogg J,Luker KA. Decision-making role preferencesand information needs : a comparison of colorectal and breastcancer[J]. Health Expect, 1999,2(4) :266-276.
  • 9Tariman JD,Berry DL,Cochrane B,et al. Preferred and actualparticipation roles during health care decision making inpersons with cancer:a systematic review [J]. Ann Oncol,2010,21(6):1145-1151.
  • 10McGuire AL,McCullough LB,Weller SC,et al. Missed expec-tations. Physicians, views of patients, participation in medicaldecision-making[J]. Med Care,2005,43(5) :466-470.

共引文献158

同被引文献26

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部